Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amylyx Pharmaceuticals (AMLX) Prepaid Assets (2021 - 2025)

Amylyx Pharmaceuticals (AMLX) has 5 years of Prepaid Assets data on record, last reported at $6.6 million in Q4 2025.

  • For Q4 2025, Prepaid Assets fell 47.1% year-over-year to $6.6 million; the TTM value through Dec 2025 reached $6.6 million, down 47.1%, while the annual FY2025 figure was $6.6 million, 47.1% down from the prior year.
  • Prepaid Assets reached $6.6 million in Q4 2025 per AMLX's latest filing, down from $9.3 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $17.3 million in Q3 2023 and bottomed at $5.4 million in Q4 2021.
  • Average Prepaid Assets over 5 years is $10.9 million, with a median of $10.3 million recorded in 2022.
  • Peak YoY movement for Prepaid Assets: soared 107.99% in 2023, then crashed 53.5% in 2025.
  • A 5-year view of Prepaid Assets shows it stood at $5.4 million in 2021, then skyrocketed by 87.56% to $10.1 million in 2022, then soared by 47.64% to $14.9 million in 2023, then decreased by 16.39% to $12.5 million in 2024, then tumbled by 47.1% to $6.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Prepaid Assets were $6.6 million in Q4 2025, $9.3 million in Q3 2025, and $6.0 million in Q2 2025.